European Commission President Ursula von der Leyen, second right, speaks with German scientist, CMO and co-founder of BioNTech Ozlem Tureci, right, Pfizer CEO Albert Bourla, left, and Belgium's Prime Minister Alexander De Croo, second left, during an official visit to the Pfizer (John Thys, Pool via AP)
October 11, 2022 11:07 AM EDTUpdated October 14, 10:38 AM
Deals
Pharma
Coronavirus

Pfiz­er ex­ec de­nies vac­cine ne­go­ti­a­tions via text mes­sage in grilling be­fore Eu­ro­pean Par­lia­ment

Nicole DeFeudis

Editor

Amid what one mem­ber of the Eu­ro­pean Par­lia­ment called “SMS-gate,” a Pfiz­er ex­ec­u­tive on Mon­day de­nied that the com­pa­ny’s vac­cine deal with the bloc could …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

FDA ad­comm rais­es risk ques­tions on As­traZeneca’s An­dexxa

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times